- Home
- NCPL vs PAVM Comparison
NCPL vs PAVM Comparison
Compare NCPL & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NCPL | PAVM |
|---|---|---|
| Founded | 1984 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.2M | 9.3M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | NCPL | PAVM |
|---|---|---|
| Price | $0.92 | $0.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $20.00 |
| AVG Volume (30 Days) | 372.3K | ★ 501.8K |
| Earning Date | 12-12-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $917,291.00 | $29,000.00 |
| Revenue This Year | $739.37 | N/A |
| Revenue Next Year | N/A | $450.56 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.63 | $0.30 |
| 52 Week High | $8.75 | $1.25 |
Technical Indicators
Market Signals| Indicator | NCPL | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 32.89 | 44.93 |
| Support Level | $0.81 | $0.31 |
| Resistance Level | $1.26 | $0.39 |
| Average True Range (ATR) | 0.26 | 0.04 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 22.22 | 23.66 |
Price Performance
Historical ComparisonAbout NCPL Netcapital Inc.
Netcapital Inc is a financial technology company. The company facilitates the growth of private companies by providing fundraising services and other consulting services. The company's online private investment platform connects entrepreneurs and investors, enabling companies to raise capital digitally. The Company operates in a single operating segment, which is the provision of fintech services.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, esocheck, and the Veris Cancer Care Platform.